Bristol Urology Associates Ltd. - Accounts to registrar (filleted) - small 18.2

Bristol Urology Associates Ltd. - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.1.0.635 04283855 Board of Directors 26.9.18 25.9.19 25.9.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure042838552018-09-25042838552019-09-25042838552018-09-262019-09-25042838552017-09-25042838552017-09-262018-09-25042838552018-09-2504283855ns15:EnglandWales2018-09-262019-09-2504283855ns14:PoundSterling2018-09-262019-09-2504283855ns10:Director12018-09-262019-09-2504283855ns10:PrivateLimitedCompanyLtd2018-09-262019-09-2504283855ns10:SmallEntities2018-09-262019-09-2504283855ns10:AuditExempt-NoAccountantsReport2018-09-262019-09-2504283855ns10:SmallCompaniesRegimeForDirectorsReport2018-09-262019-09-2504283855ns10:SmallCompaniesRegimeForAccounts2018-09-262019-09-2504283855ns10:FullAccounts2018-09-262019-09-250428385512018-09-262019-09-2504283855ns10:Director22018-09-262019-09-2504283855ns10:Director32018-09-262019-09-2504283855ns10:Director42018-09-262019-09-2504283855ns10:RegisteredOffice2018-09-262019-09-2504283855ns5:CurrentFinancialInstruments2019-09-2504283855ns5:CurrentFinancialInstruments2018-09-2504283855ns5:ShareCapital2019-09-2504283855ns5:ShareCapital2018-09-2504283855ns5:RetainedEarningsAccumulatedLosses2019-09-2504283855ns5:RetainedEarningsAccumulatedLosses2018-09-2504283855ns5:NetGoodwill2018-09-262019-09-2504283855ns5:IntangibleAssetsOtherThanGoodwill2018-09-262019-09-2504283855ns5:PlantMachinery2018-09-262019-09-2504283855ns5:NetGoodwill2018-09-2504283855ns5:NetGoodwill2019-09-2504283855ns5:NetGoodwill2018-09-2504283855ns5:LandBuildings2018-09-2504283855ns5:PlantMachinery2018-09-2504283855ns5:LandBuildings2018-09-262019-09-2504283855ns5:LandBuildings2019-09-2504283855ns5:PlantMachinery2019-09-2504283855ns5:LandBuildings2018-09-2504283855ns5:PlantMachinery2018-09-2504283855ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-09-2504283855ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-09-25
REGISTERED NUMBER: 04283855 (England and Wales)















Unaudited Financial Statements for the Year Ended 25 September 2019

for

Bristol Urology Associates Ltd.

Bristol Urology Associates Ltd. (Registered number: 04283855)






Contents of the Financial Statements
for the Year Ended 25 September 2019




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Bristol Urology Associates Ltd.

Company Information
for the Year Ended 25 September 2019







DIRECTORS: A Koupparis
Professor R A Persad
J Philip
T H Whittlestone





REGISTERED OFFICE: First Floor
29 St Augustine's Parade
Bristol
BS1 4UL





REGISTERED NUMBER: 04283855 (England and Wales)





ACCOUNTANTS: Moore
First Floor
29 St Augustine's Parade
Bristol
BS1 4UL

Bristol Urology Associates Ltd. (Registered number: 04283855)

Balance Sheet
25 September 2019

25.9.19 25.9.18
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 34,629 21,097
34,629 21,097

CURRENT ASSETS
Stocks 7,151 7,151
Debtors 6 359,016 488,993
Cash at bank and in hand 140,823 114,574
506,990 610,718
CREDITORS
Amounts falling due within one year 7 140,593 190,918
NET CURRENT ASSETS 366,397 419,800
TOTAL ASSETS LESS CURRENT
LIABILITIES

401,026

440,897

PROVISIONS FOR LIABILITIES 5,238 3,810
NET ASSETS 395,788 437,087

CAPITAL AND RESERVES
Called up share capital 1,333 1,333
Retained earnings 394,455 435,754
395,788 437,087

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 25 September 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 25 September 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as
at the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

Bristol Urology Associates Ltd. (Registered number: 04283855)

Balance Sheet - continued
25 September 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on
6 August 2020 and were signed on its behalf by:





A Koupparis - Director


Bristol Urology Associates Ltd. (Registered number: 04283855)

Notes to the Financial Statements
for the Year Ended 25 September 2019

1. STATUTORY INFORMATION

Bristol Urology Associates Ltd. is a private company, limited by shares , registered in England and
Wales. The company's registered number and registered office address can be found on the
Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business, has been
amortised evenly over its useful estimated life, and now stands at a net book value of nil in the
accounts.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are
measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for
obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income
Statement, except to the extent that it relates to items recognised in other comprehensive income
or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.


Bristol Urology Associates Ltd. (Registered number: 04283855)

Notes to the Financial Statements - continued
for the Year Ended 25 September 2019

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed
at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that
are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is
probable that they will be recovered against the reversal of deferred tax liabilities or other future
taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the
period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2018 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 26 September 2018
and 25 September 2019 30,000
AMORTISATION
At 26 September 2018
and 25 September 2019 30,000
NET BOOK VALUE
At 25 September 2019 -
At 25 September 2018 -

Bristol Urology Associates Ltd. (Registered number: 04283855)

Notes to the Financial Statements - continued
for the Year Ended 25 September 2019

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 26 September 2018 734 189,956 190,690
Additions - 25,076 25,076
At 25 September 2019 734 215,032 215,766
DEPRECIATION
At 26 September 2018 734 168,859 169,593
Charge for year - 11,544 11,544
At 25 September 2019 734 180,403 181,137
NET BOOK VALUE
At 25 September 2019 - 34,629 34,629
At 25 September 2018 - 21,097 21,097

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
25.9.19 25.9.18
£    £   
Trade debtors 347,287 472,079
Other debtors 11,729 16,914
359,016 488,993

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
25.9.19 25.9.18
£    £   
Trade creditors 10,610 12,722
Taxation and social security 108,427 160,775
Other creditors 21,556 17,421
140,593 190,918